Search results
Found 547 matches for
Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, has raised $2M in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery.
"We loved being in the BioEscalator, and part of the community, and the support and flexibility from the BioEscalator team was invaluable."
Hollie Coe, Base Genomics (now Exact Sciences Innovation)
"The high-quality facilities, resources and support to grow a company were invaluable."
Tim Funnell, MiroBio (now Gilead)
